Filter Results
Clinical Studies
Results filtered:Study status:
Closed for Enrollment
Closed for Enrollment
-
Methylphenidate and Pharmacogenomic Calibration Study (MAPS) (MAPS)
Rochester, Minn.
The purpose of this study is to evaluate the predictive value of a custom designed SNP panel test on overall side effect burden caused by methylphenidate at week 8, as well as treatment response. The measure of overall side effect burden will take into account both the number and severity of side effects.
.